Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase

by Savitha C Muppala on  June 3, 2011 at 10:42 PM Cancer News
RSS Email Print This Page Comment
Font : A-A+

A new drug to treat triple-negative breast cancer is ready to undergo testing.

A group of 15 genes responsible for accelerating the growth of cancer has been found by researchers at the Dana-Farber Cancer Institute in Boston.
 Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase
Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase

This finding has paved the way for clinical trials on a drug which promises to retard or stop the development of triple-negative breast cancer tumors.

Currently, triple negative breast cancers affects more than 40,000 women annually. With these clinical trials, researchers are hoping to arrive at specific therapies to treat triple-negative breast cancers effectively.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive